Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs

Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs

FromInvestors' Chronicle


Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs

FromInvestors' Chronicle

ratings:
Length:
30 minutes
Released:
Sep 16, 2022
Format:
Podcast episode

Description

On this week's Companies and Markets show, the team discuss a reality check for hydrogen hope ITM Power (ITM), whose annual results sparked a steep sell-off in the company’s shares on Wednesday.Economics writer Hermione Taylor then outlines the debate over ‘Trussonomics’, looking at government policies and their potential impact on the UK economy, sterling, and the gilt market.Last but not least, Jennifer Johnson runs the rule over latest figures from Advanced Medical Solutions (AMS) and Abcam (ABC), as well as the latter’s plans to delist from Aim.Dan Jones hosts Julian Hofmann, Hermione Taylor, Jennifer Johnson and Alex Newman. Hosted on Acast. See acast.com/privacy for more information.
Released:
Sep 16, 2022
Format:
Podcast episode

Titles in the series (100)

Concerned with QE's effects on equity valuations? Looking for ideas for your Isa? Or just plain confused by the stock market? Each week, the Investors Chronicle picks apart the latest news for companies, markets and funds in our regular magazine podcasts. Subscribe for these, along with CEO interviews, company-specific shows and special in-depth discussions on big market themes. Hosted on Acast. See acast.com/privacy for more information.